Banyan Ventures AI Fund I invested in Biological Black Box (BBB) because of its innovative approach to AI computing infrastructure, addressing critical limitations in current silicon-based technologies.
Current silicon chips face significant constraints, including high energy use, heat generation, and difficulties scaling efficiently with evolving AI demands. BBB provides a new way forward by creating computing hardware integrated with actual living neurons—derived from either human stem cells or rat cells—using their unique Bionode platform. Neurons in Bionode physically adapt and rewire themselves in real-time, improving efficiency and enabling continuous learning without needing to rebuild or retrain traditional silicon models.
BBB’s Bionode operates as a closed-loop continuous reinforcement learning system. Practically, this means neurons learn by physically rearranging themselves in response to new data, offering direct performance improvements and lower power consumption. The company demonstrated nearly a 5x efficiency improvement on transformer model inference, a notable achievement given the complexity and energy demands of current AI workloads.
The commercialization strategy of BBB is already underway. They have developed multiple distinct product lines, including:
BBB already holds Letters of Intent from prominent companies F-500, validating their commercial relevance and technological capabilities.
Banyan Ventures believes BBB's founders, Alexander Ksendzovsky and Jonathan Pomeraniec, have built a uniquely capable team positioned to lead biological computing innovation. Their approach represents a significant advancement in AI computing infrastructure, promising substantial efficiency gains, cost reductions, and adaptability that silicon-based hardware simply cannot match.
More detailed updates and discussions about BBB’s technology and progress will follow in future posts. To learn more about BBB read:
